Reports
Over-the-counter anti-inflammatory pain relievers have risen in demand among patients who need pain relievers that can also supress inflammation. Among the various classes, nonsteroidal anti-inflammatory drugs (NSAIDs) have attracted a considerable attention among drug makers as well as the target consumers for managing range of conditions, notable of which are muscle pain, arthritic conditions, pyrexia, migraines, and dysmenorrhea. The anti-inflammatory pain relievers market is gaining valuation on he back of growing awareness about the efficacy and safety profile of various NSAIDs. A great deal of the related developments has hinged on growing research on understanding the blocking mechanism of NSAIDs. Some NSAIDs can be administered parenterally, and as opioid-sparing agents, which has fueled its demand in hospital settings.
Growing demand for certain pain relievers for long-term management of arthritis symptoms is also a key trend fueling lucrative avenues for drugmakers in the anti-inflammatory pain relievers market. Over the years, the demand for overt-the-counter NSAIDs has grown strikingly in developed nations, which has led to concerns about the side-effects. Of all the adverse event risks, those associated with heart complications may be fatal. The worldwide prevalence of cardiovascular disease (CVD) has further compounded the problem of indiscriminate use of OTC drugs. Nevertheless, favorably regulatory frameworks for development and marketing of anti-inflammatory agents are expected to set the tone for rapid product advancements.
The global anti-inflammatory pain reliever drugs market is anticipated to grow at a significant pace, thanks to the widening use of anti-inflammatory pain reliever drugs.
Anti-inflammatory pain relievers are medicines that reduce or relieve headaches, arthritis, sore muscles, and other aches and pains. There are several types of anti-inflammatory pain reliever drugs depending upon type of pain, while each of them have different advantages and risks.
An upcoming report on anti-inflammatory pain reliever drugs market by Transparency Market Research is expected to offer an in depth analysis on industry. The report is anticipated to cover all the segments of anti-inflammatory pain reliever drugs market. Along with this, the report is anticipated to consists of vital data that will help indicating growth and latest trend in the anti-inflammatory pain reliever drugs market during the forecast period.
Some of the recent development in the anti-inflammatory pain reliever drug market are-
Researchers found several novel uses for old anti-inflammatory drugs. This is expected to widen application of drugs for several other purpose. For example, aspirin, a common pain reliever can also be used to help prevent heart attack, stroke, or certain cancers. This is because of the compound found in aspirin helps in relaxing muscles thus has a temporary effect on hearth attack cure as well. Likewise, several other, anti-inflammatory pain relievers might also have health benefits.
The global anti-inflammatory pain reliever drugs market is likely to rise a fast pace in the coming few years. This is mainly due to increasing prevalence of disease across the globe. Apart from this, easy availability of these is another strong expected to drive the global anti-inflammatory pain reliever drugs market
However, several side effects due to the consumption and habit forming nature of anti-inflammatory pain reliever drugs are some factor expected to hinder prospects of the global anti-inflammatory pain reliever drugs market in the coming few years.
Nevertheless, rise in number of surgeries, increase in geriatric population and rising adoption of anti-inflammatory pain reliever drugs by people are some other factor likely to offer a significant boost to the anti-inflammatory pain reliever drugs market in the coming few years.
Based on geography the healthcare staffing market is divided into North America, Asia Pacific, Europe, and the Middle East and Africa. Among all these regions, Asia Pacific is expected to hold a significant share in the anti-inflammatory pain reliever drugs market. This is mainly because of easy availability of anti-inflammatory pain reliever drugs in the region. In most countries of the region, these drugs are available without medical prescription. North America is likely to hold a major share in the healthcare staffing market.
The global anti-inflammatory pain reliever drugs market depicts a fragmented and competitive landscape with the presence of large number of players. Some of the prominent players operating in the market are Cipla, Sun Pharma Industries, and Sanofi, IPCA laboratories
These players are adopting several strategies such as product launches, merger and acquisition, business expansion and collaboration to concretize their market position. Apart from this, players are launching anti-inflammatory pain reliever drugs in the form of gel, liquid and spray so as improve their effect and help consumer in easy application. This is expected to fuel the market growth in the coming few years.
N/A